Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 Nanodispersion in Parkinson's Disease
NCT00180037Phase 3Completed
- Sponsor
- Technische Universität Dresden
- Start
- Sep 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Coenzyme Q10 with Placebo (2 arms). Primary endpoint: Unified Parkinson's Disease Rating Scale Part II and III. Started Sep 2003; status: completed.
02
Drugs
coenzyme q10
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00180037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180037.